Dr. Sarah Mitchell

Medical Oncology · Royal Marsden Hospital, London

★ 7.4k1 questions2 answers (1 accepted)Joined Apr 20262 publications

Questions (1)

Immune checkpoint inhibitor rechallenge after grade 3 myocarditis: is it ever safe?

Answers (2)

Immune checkpoint inhibitor rechallenge after grade 3 myocarditis: is it ever safe?

CAR-T cell therapy vs bispecific antibodies for pediatric relapsed B-ALL after second relapse: sequencing and selection?

Publications (2)

Optimal Sequencing of Immunotherapy for Pediatric B-Cell Acute Lymphoblastic Leukemia with Second Relapse Post-Allogeneic Hematopoietic Stem Cell Transplantation: A Clinical Consensus

TDX-2026-00024Apr 202665 votes2 contributorsAccepted Answer Author

Immune Checkpoint Inhibitor Rechallenge After Grade 3 Myocarditis in Metastatic Melanoma: A Community Peer-Reviewed Clinical Consensus and Management Framework